) is a hepatotoxin widely used in animal models, biotransformed by hepatic microsomal cytochrome P 450 to produce the trichloromethyl free radicals [5] which can react with sulfhydryl groups, such as reduced glutathione (GSH) and protein thiols. Covalent binding of trichloromethyl free radicals to cell protein is considered to be the initial step in a chain of events that eventually lead to membrane lipid peroxidation and finally to cell apoptosis and necrosis [6] . There is a paradigm shift to the use of complementary and alternative therapies for the management of liver diseases as a result of limited efficacy and serious adverse effects of the conventional therapies [7] . Moreover, the search for new drugs capable of alleviating liver injury with fewer side effects and satisfactory therapeutic outcome has increased over the years.
Introduction

▼
The liver is the largest organ in the human body, it has the enormous task of maintaining the body's metabolic homeostasis, necessary for metabolism of drugs and exogenous toxins. Liver damage is a prevalent pathology that involves a variety of disorders including oxidative stress, steatosis, hepatitis, fibrosis, cirrhosis, apoptosis and hepatocellular carcinoma [1] . Liver diseases are one of the major causes of mortality and morbidity worldwide [2] . They are mainly caused by toxic chemicals, excessive consumption of alcohol, infections and autoimmune disorders. Most of the hepatotoxic chemicals damage liver cells by inducing lipid peroxidation and oxidative stress [3] . Cell damage results from the increased generation of reactive species from oxygen and nitrogen or deficiency of antioxidants [4] . Carbon 400 mg/kg/day for 7 days, p.o.) was investigated in male Sprague Dawley rats against carbon tetrachloride (CCl 4 /olive oil, 1:1, 0.7 ml/kg, i.p.)-induced liver damage. At the end of the study, blood samples and liver tissue were assayed for biochemical and antioxidants parameters. Results: Hepacare produced concentration dependent inhibition of DPPH and nitric oxide activity with IC 50 of 48.50 and 55.00 µg/ml, respectively, it suppressed the absorbance of
ABTS
. + with total antioxidant capacity of 423.47 ± 8.37 mg QUE/g. CCl 4 administration induced significant (P < 0.001) elevation of serum aspartate transaminase (1.70 fold), alanine transaminase (1.60 fold), alkaline phosphatase (2.90 fold) and bilirubin (2.00 fold) in comparison to control. The increase in serum biomarker were dose-dependently reversed by Hepacare ® pretreatment.
More over, CCl 4 pretreatment increased (P < 0.001) malondialdehyde (MDA) (73.98 %) and decreased (P < 0.001) antioxidant enzymes level but Hepacare pretreatment produced dose-dependent attenuation of the increased MDA (3.84 fold) with enhancement of glutathione (3.08 fold), superoxide dismutase (2.08 fold), and catalase (3.14 folds) levels in comparison to CCl 4 treated group, similar to those of silymarin reference standard.
Conclusion:
Hepacare was beneficial in the prevention of CCl 4 -induced hepatocellular injury, possibly by scavenging reactive free radicals, and boosting endogenous antioxidant systems.
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In vitro evaluation of antioxidant activities DPPH radical scavenging activity assay
The free radical scavenging capacity of Hepacare ® was determined using the stable free radical DPPH [8] . Hepacare was mixed with 95 % ethanol to prepare a stock solution (5 mg/ml). DPPH solution (0.004 %, w/v) was prepared in 95 % ethanol. A freshly prepared DPPH solution (0.004 %, w/v) was placed in test tubes and Hepacare ® was added followed by serial dilution (25 μg to 150 μg) in every test tube so that the final volume was 3 ml. After 10 min, the absorbance was read at 515 nm using a spectrophotometer (HACH 4000 DR UV-visible spectrophotometer, USA). Ascorbic acid (5 mg/ml in distilled water) was used as a reference standard. A control sample of the same volume was prepared without any extract and reference ascorbic acid. A solution of 95 % ethanol served as a blank. The percentage ( %) scavenging of the DPPH free radical was calculated using the following equation:
% scavenging activity = Absorbance of the control − Absorbance of the test sample/Absorbance of the control × 100
The IC 50 value is the concentration of the sample required to inhibit 50 % of the radical [9] .
Total antioxidant capacity assay
The antioxidant activity of the extract was evaluated by the phosphomolybdenum method in accordance with the procedure described by Prieto et al. [10] . The assay is based on the reduction of Mo (VI) to Mo (V) by the extract and subsequent formation of a green phosphate/Mo (V) complex at an acidic pH. 0.3 ml Hepacare ® was combined with 3 ml of reagent solution (0.6 M sulphuric acid, 28 mM sodium phosphate, and 4 mM ammonium molybdate). Test tubes containing the reaction solution were incubated at 95 °C for 90 min. The absorbance of the solution was then measured against a blank at 695 nm using a spectrophotometer (HACH 4000 DU UV-visible spectrophotometer) after the solution cooled to room temperature. Ethanol (0.3 ml) in the place of extract/sample served as the blank. Antioxidant activity was expressed as the number of gram equivalents of ascorbic acid.
Determination of total phenol content
Total phenol content in the Hepacare ® was determined with
Folin-Ciocalteu reagent. Hepacare ® (200 μg/ml) was mixed with 400 μl of the Folin-Ciocalteu reagent and 1.5 ml of 20 % sodium carbonate. The mixture was shaken thoroughly and made up to 10 ml using distilled water. The mixture was allowed to stand for 2 h. The absorbance at 765 nm was then determined. The total phenol content in Hepacare ® was then determined as the mg of gallic acid equivalent using equations that were obtained from a standard gallic acid graph [11] .
Determination of total flavonoid content
The total flavonoid content was determined using a method previously described by Kumaran and Karunakaran [12] . 1 ml of Hepacare ® in ethanol (200 μg/ml) was mixed with 1 ml of aluminium trichloride in ethanol (20 mg/ml) and a drop of acetic acid and then diluted with ethanol to 25 ml. The absorption at 415 nm was read after 40 min. Blank samples were prepared from 1 ml of Hepacare and a drop of acetic acid and then diluted to 25 ml with ethanol. The total flavonoid content was determined using a standard curve for quercetin (12.5-100 μg/ml) and was expressed as mg of quercetin equivalent (QUE/g of extract).
Determination of total tannins content
A total of 500 mg of Hepacare was extracted with 300 ml of diethyl ether for 20 h at room temperature. The residue was boiled for 2 h with 100 ml of distilled water, and then allowed to cool, and was filtered. The extract was adjusted to a volume of 100 ml in a volumetric flask. The content of tannins in the extract was determined colorimetrically using Folin-Denis reagent, by measuring absorbance of the blue complex at 760 nm, using tannic acid solution as a standard solution [13] .
Reducing power assay
The reducing capacity of a compound may serve as a good indicator of its potential antioxidant property. The reducing capacity of Hepacare was investigated using Fe 3 + -Fe 2 + transformation. 2.5 ml of 10 % trichloroacetic acid solution was added to each test tube and the mixture was centrifuged at 3 000 rpm for 10 min, subsequently, 5 ml of the upper layer solution was mixed with 5 ml of distilled water and 1 ml of ferric chloride solution (0.1 %, w/v) and the absorbance was measured at 700 nm. The reducing power of the extract was linearly proportional to the concentration of the sample. Ascorbic acid served as the reference standard. Phosphate buffer (pH 6.6) served as the blank solution.
Nitric oxide radical scavenging
At physiological pH, nitric oxide generated from aqueous sodium nitroprusside (SNP) solution interacts with oxygen to produce nitrite ions, which may be quantified by the Griess Illosvoy reaction [15] . The reaction mixture contained 10 mM SNP, phosphate buffered saline (pH 7.4) and various doses (0-70 μg/ml) of the test solution in a final volume of 3 ml. After incubation for 150 min at 25 °C, 1 ml sulfanilamide (0.33 % in 20 % glacial acetic acid) was added to 0.5 ml of the incubated solution and allowed to stand for 5 min. Then 1 ml of napthylethylenediamine dihydrochloride (NED) (0.1 % w/v) was added and the mixture was incubated for 30 min at 25 °C. The pink chromophore generated during diazotization of nitrite ions with sulphanilamide and subsequent coupling with NED was measured spectrophotometrically at 540 nm against a blank sample. All tests were performed 6 times. Ascorbic acid was used as a standard.
Animals
Male Sprague Dawley rats (150-200 g) and female Swiss albino mice (20-25 g) used in this study were obtained from the Laboratory Animal Centre of the College of Medicine, University of Lagos, Lagos, Nigeria. The animals were maintained in a 12 h light/dark cycle, at constant temperature (23 ± 2 °C) and humidity (50 ± 10 %). After 1 week of acclimatization, animals had free access to food and water. The experimental procedures adopted in this study was approved by College of Medicine, Research grant and experimentation committee and in strict compliance with the United States National Institutes of Health Guidelines for Care and Use of Laboratory Animals in Biomedical Research [16] .
Acute toxicity study
Mice were generally fasted for 12 h before the test. Mice (n = 6) received either distilled water 10 ml/kg or Hepacare (500, 1 000 and 2 000 mg/kg, p.o.). Mice were observed for toxic symptoms and behavioural changes such as (sedation, hyperactivity, diarrhoea, writhing, piloerection, and restlessness) for 2 h postadministration and 14 days for signs of delayed toxicity or mortality.
Hepatoprotective and in vivo antioxidant activity
The method of Habbu et al. [17] was used in this study. Rats were divided into 9 groups of 5 animals each. CCl 4 was given on alternate days for a period of 7 days. Control, test and standard agents were administered for 7 successive days. On the 7 th day, animals were sacrificed by cervical dislocation and blood was withdrawn into plain bottles by cardiac puncture. The blood was allowed to coagulate for 30 min and serum was separated by centrifugation. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin, total bilirubin, and total protein were estimated using Roche and Cobas commercial kits and Roche/Hitachi 904 automated analyser. The liver tissue was isolated for weight determination (using Mettler-Toledo GmbH digital weighing balance [Type BD202, SNR 06653]), to measure the levels of antioxidant enzymes, malondialdehyde (MDA) and for histopathological studies.
Measurement of antioxidant enzymes and MDA levels
Measurement of antioxidant enzymes activity and MDA level was done according to standard procedures: catalase [18] ; superoxide dismutase (SOD) [18] ; reduced glutathione [18] ; and MDA [18] .
Histopathological studies
After rats were sacrificed, the livers of each rat was identified and carefully extracted. Sections were immediately taken from each lobe of the liver. The tissues were fixed in 10 % formo-saline, dehydrated in graded alcohol and embedded in paraffin. These were then cut into 4-5 µm thick sections and stained with haematoxylin-eosin for photomicroscopic assessment [17, 19] using a Model N-400ME photomicroscope (CEL-TECH Diagnostics, Hamburg, Germany).
Statistical analysis
Results are expressed as mean ± SEM (n = 5). Statistical significance of differences between groups was determined by ANOVA followed by Tukey post-hoc multiple comparison test. A probability (P) value of less than 0.05 was taken to indicate statistical significance. Linear regression analysis was used to calculate IC 50 values.
Results
▼
Total antioxidant activity
The total antioxidant activity of the extract was calculated from the decolourization of ABTS . + , which was measured spectrophotometrically at 734 nm. Interaction with the Hepacare or standard quercetin suppressed the absorbance of the ABTS . + radical cation, the total antioxidant capacity of Hepacare was 423.47 ± 8.37 mg QUE/g ( • ▶ Fig. 1 ).
Determination of total phenolic, flavonoid and tannin contents
Phenolic compounds such as flavonoids, phenolic acids, and tannins are considered to be major contributors to the antioxidant capacity of plants. Phenolic compounds may contribute directly to antioxidative action. The total phenolic content of the sample, calculated on the basis of the standard curve for gallic acid, was found to be 342. DPPH activity, and the scavenging activities of the extract and known antioxidants increased with increasing concentration. At higher concentration (100 μg/ml), the extract and known antioxidants gave the highest percentage activities; (77.53 %) and (84.00 %), respectively. In addition, the IC 50 was estimated to be 48.50 µg/ml and 36.50 µg/ml for Hepacare and ascorbic acid, respectively. These results suggest that Hepacare possesses free radical scavenging effect.
Reducing power assay
It depends on the ability of Hepacare to reduce the ferric tripyridyltriazine (Fe(III)TPTZ) complex to ferrous tripyridyltriazine (Fe(II)TPTZ) at a low pH. (Fe(II)TPTZ) has an intensive blue colour which can be read at 593 nm. As illustrated in • ▶ Fig. 3 Fig. 3 ).
Nitric oxide inhibitory activity
Hepacare caused a moderate dose-dependent inhibition of nitric oxide with an IC 50 of 55.00 µg/ml ( • ▶ Fig. 4) . Ascorbic acid was used as a reference and 47.50 µg/ml was needed for 50 % inhibition. The IC 50 value of Hepacare was greater than that of the standard. Moreover, there was a strong correlation between nitric oxide inhibitory effect of Hepacare and ascorbic acid.
Effect of Hepacare on serum markers of liver damage
No difference in serum AST, ALT, ALP or bilirubin concentration was detected between distilled water and olive oil (10 ml/kg/day for 7 days) pretreated animals indicating that the vehicles used in these experiments were devoid of hepatotoxic activity ( • ▶ Fig. 4a-d) . However, significant (P < 0.001) increases in serum aspartate aminotransferase (1.7 fold vs. vehicle treated control), alanine aminotransferase (1.6 fold vs. vehicle treated control), alkaline phosphatase (2.9 fold vs. vehicle treated control), and bilirubin (2.0 fold vs. vehicle treated control) were observed following subchronic injection of carbon tetrachloride. In contrast, pretreatment with Hepacare significantly (P < 0.001) and dosedependently reversed the increase in markers of liver injury with peak protective effect at 400 mg/kg/day, serum aspartate aminotransferase ( Fig. 5a-d) .
MDA level
As a parameter of lipid peroxidation, the concentration of malondialdehyde was determined in samples of liver obtained from distilled water, olive oil, CCl 4, and Hepacare pre-treated rats. No significant change in MDA level was observed in distilled water and olive oil non-treated rats. However, CCl 4 pretreatment significantly increased (P < 0.001) malondialdehyde level (73.98 %) in comparison to control treated. One way ANOVA revealed that oral administration of Hepacare (50-400 mg/kg) significantly [3.84 fold; F (8, 61) = 13.13, P < 0.0001]) attenuated CCl 4 -induced increase in lipid peroxidation with peak effect at 400 mg/kg ( • ▶ Fig. 6 ). The ability of silymarin to significantly reduced MDA generation by 3.84 fold was not significantly (P > 0.05) different from protective effect of Hepacare pretreated rats. Similarly, Hepacare (400 mg/kg) only pretreated rats did not induce lipid peroxidation.
GSH level
Intraperitoneal injection of CCl 4 induced significant (P < 0.001) deficit in glutathione level (2.90 fold) in comparison to control. However, Hepacare (100-400 mg/kg) pretreatment produced dose dependent and significant [3.08 fold; F (8, 61) = 11.67, P < 0.0001]) increase in glutathione level following deficit induced by CCl 4 pretreatment. Furthermore, silymarin treated significantly (P < 0.001) enhanced glutathione level which was similar to the protective effect of Hepacare ( • ▶ Fig. 7 ).
SOD level
Intraperitoneal injection of CCl 4 induced significant (P < 0.001) reduction (2.01 fold) in the level of superoxide dismutase in the liver in comparison to vehicle only treated. Interestingly, the Fig. 9 ).
Moreover, silymarin pretreatment produced significant (P < 0.01) increase in catalase level that was similar to the peak effect of Hepacare 400 mg/kg.
Histology of the liver
Distilled water treatment did not affect architecture of the liver cells ( • ▶ Fig. 10a) , moreover inflammatory cells were seen sur- of the antioxidants. A large decrease in the absorbance of the reaction mixture indicates significant free radical scavenging activity of the compound under test [8] . Results of this study suggest that Hepacare ® contain phytochemical constituents that are capable of donating hydrogen to a free radical to scavenge the potential damage. The antiradical properties of this extract could be linked to the presence of phenolic compounds. The reducing ability of a compound depends on the presence of reductants, which will break the free radical chain by donating a hydrogen atom [28] . Moreover, the reducing power of secondary metabolites from medicinal plants prevents liver injury by inhibiting formation of lipid peroxides [29] . Furthermore, the reducing power of Hepacare increased with increase in concentration, suggesting a potential reductants [30] , in addition, the ferrous ion chelating properties of an antioxidant extract could be attributed to their endogenous chelating agents, mainly, tannins, terpenes and phenolics [31] . In reducing power assay, the yellow colour of the test solution changes to green depending on the reducing power of the test specimen. The presence of the reductants in the solution causes the reduction of the Fe 3 + /ferricyanide complex to the ferrous form. Therefore, Fe 2 + can be monitored by absorbance measurement at 700 nm. Increasing absorbance at 700 nm indicates an increase in reducing ability. The antioxidants present in the extract of Hepacare ® caused the reduction of Fe3 + / ferricyanide complex to the ferrous form, and thus proved the reducing power. This showed that Hepacare reacts with free radicals to convert them to more stable products, hence terminate radical chain reaction. Despite much study, the precise role of nitric oxide (NO) in liver damage induced by hepatotoxicants remains unclear (hepatoprotective and hepatotoxic). However, the study of Gardener et al., [32] showed that aminoguanidine (inducible nitric oxide synthase (iNOS) enzyme inhibitor) reduces the resulting hepatic necrosis and associated increases in serum aspartate and alanine aminotransferase activity. It was concluded that NO derived from iNOS is hepatotoxic possibly as a result of the formation of damaging free radical species such as peroxynitrite. Interestingly, Hepacare and ascorbic acid dose dependently attenuated in vitro nitric oxide generation. In this study, intraperitoneal administration of CCl 4 on alternate days for a period of 7 days induced liver injury in rats. The liver injury induced by CCl 4 is the best characterized system for xenobiotic-induced hepatotoxicity and are commonly used models for screening of the anti-hepatotoxic and/or hepatoprotective activities of drugs [30, 31] . This in vivo study showed that serum ALT, AST, ALP and, total bilirubin activities and hepatic MDA increased in parallel with CCl 4 injection, with concomitant GSH, SOD, and catalase deficit indicating the induction of acute hepatotoxicity by CCl 4 [32] . The acute hepatotoxic effects induced by CCl 4 administration were confirmed histopathologically, revealing extensive sinusoidal haemorrhage, and hepatocellular degeneration. The obtained results are in accordance with those of the previous reports [32] . However, Hepacare pretreatment significantly attenuated the CCl 4 -induced increase in serum activities of ALT, AST and ALP, and reduced hepatic lipid peroxidation. Histological observations of the livers also strongly support the hepatoprotective effect of Hepacare. The return of elevated levels of serum enzymes to near normal values in groups treated with Hepacare or standard silymarin is an indication of the stabilization of the plasma membrane and the repair of hepatic tissue damage caused by CCl 4 . In addition, these results indicated the rounding the portal tract in olive oil treated group ( • ▶ Fig. 10b) . Fig. 10h ).
Discussion
▼
Findings from this study revealed significant antioxidant property of Hepacare ® both from in vitro and in vivo biological investigation as possible mechanism for its hepatoprotective effect against CCl 4 -induced liver injury in rats. It has been hypothesized that one of the principle causes of CCl 4 -induced liver injury is lipid peroxidation, induced by free radical derivatives of CCl 4 [20] . Thus, antioxidant activity, or the inhibition of the generation of free radicals, is important in the protection against CCl 4 -induced liver injury. The antioxidants activity of medicinal plants is well correlated with their polyphenolic constituents [21] . Polyphenols constitute a large and complex category of compounds and flavonoids represent the most studied group of this category for their important biological activities, such as anti-inflammatory, anti-viral and anti-cancer actions [22] which could be linked to their antioxidant and free radical scavenging effect. The use of medicinal plants with high level of antioxidant constituents has been proposed as an effective therapeutic approach for hepatic damages [23] . Antioxidant compounds like phenolic acids, polyphenols, terpenoids and flavonoids scavenge free radicals such as peroxide, or lipid peroxyl and thus inhibit the oxidative mechanisms that lead to degenerative diseases [20] . The total antioxidant capacity of Hepacare was measured spectrophotometrically through phosphomolybdenum method, based on the reduction of Mo (VI) to Mo (V) by the test sample and the subsequent formation of green phosphate/Mo (V) compounds with a maximum absorption at 765 nm. The present study demonstrated that Hepacare ® exhibited significant and potent antioxidant capacity for phosphomolybdate reduction. Studies have shown that many flavonoid and related polyphenols contribute significantly to the phosphomolybdate scavenging activity of medicinal plants [24, 25] . Hepacare exhibited significant total phenolic, flavonoids and tannin contents. The phenolic compounds of plants are important because their hydroxyl groups confer scavenging ability [26] . The most described among groups of phenolic compounds is flavonoid which have been linked to array of biological activities due to their capacity to act as antioxidants. Based on the results obtained from this study, it could be suggested that phenolic acids and flavonoids may be the major contributors for the antioxidant activity of Hepacare. Also, compounds rich in tannins have been shown to effectively protect the liver against CCl 4 -and D-galactosamine-induced injury [27] . The electron donation ability of natural products can be measured by DPPH purplecoloured solution bleaching [23] . The method is based on scavenging of DPPH through the addition of a radical species or antioxidant that decolourizes the DPPH solution. potential protective effect of Hepacare against CCl 4 -induced liver injury. It has been recognized that oxidative stress and generation of free radicals play a critical role in CCl 4 -induced liver injury. CCl 4 toxicity is due to reactive free radical which is generated by its reductive metabolism through hepatic microsomal cytochrome P 450 to produce the trichloromethyl (CCl 3 • ), free radicals which can react with sulfhydryl groups, such as reduced glutathione (GSH) and protein thiols [33] . Covalent binding of CCl 3
• to cell proteins is considered to be the initial step in a chain of events that eventually lead to membrane lipid peroxidation and breakdown of cellular membranes [34] . High levels of reactive oxygen species (ROS) damage cells and are involved in several human pathologies, including liver cirrhosis and fibrosis. Therefore, the use of compounds with antioxidant properties may prevent or alleviate many diseases associated with ROS. However, Hepacare pretreatment attenuated CCl 4 -induced hepatocellular lipid peroxidation. The significant reduction in the level of MDA; endproduct of polyunsaturated fatty acid (PUFA) peroxidation, in Hepacare treated rats liver homogenates indicates its antilipid peroxidative effect. Pretreatment with Hepacare before intraperitoneal injection of CCl 4 increased the activity or level of GSH (i. e. attenuated GSH depletion), which scavenge free radicals and simultaneously reduce lipid peroxidation, thus alleviating the oxidative damage caused by CCl 4 . Also, SOD and catalase deficit induced by CCl 4 , were significantly increased in a dose dependent manner with the administration of Hepacare or silymarin confirming the antioxidant properties of these 2 agents obtained in in vitro models. GSH, SOD and catalase constitute mutually supportive team of defense against ROS with SOD (a metalloproteinase), which is the first enzyme involved in the antioxidant defense by lowering the steady-state level of O 2 − [35] . The hepatoprotective effect of Hepacare may at least in part be due to its phenolic and flavonoids constituents found in this preparation. The antioxidant activity of phenolic compounds is mainly due to their redox properties, which can play an important role in absorbing and neutralizing free radicals, quenching single and triplet oxygen, or decomposing peroxides [36] . As stated earlier, flavonoids possessed the ability to scavenge free radicals, inhibit hydrolytic and oxidative enzymes [37] , hence, their antiperoxidative action could be attributed to a concomitant ability to chelate iron. Flavonoids such as apigenin-7-glucoside (AP 7 Glu), luteolin-7-glucoside (LU 7 Glu) and quercetin have been reported to prevent glutathione depletion and lipid peroxidation induced by an acute intoxication with carbon tetrachloride (CCl 4 ), ethanol, acetaminophen and bromobenzene in the liver and in the rats with biliary obstruction [37] . The bestdescribed property of almost every group of flavonoids is their capacity to act as antioxidants [38] . The flavones and flavonols (apigenin, luteolin, quercetin, rutin and others) seem to be the most powerful flavonoids for protecting a body against reactive oxygen species. These compounds have the potential to scavenge and quench various radicals (oxygen-centred, carbon-centred, alkoxyl, peroxyl, or phenoxyl radicals) and reactive oxygen species. The flavonoids may have an additive effect to the endogenous scavenging compounds and also increase the function of the endogenous antioxidants. The flavonoids interrupt the lipid peroxidation chain reaction and thereby prevent glutathione depletion that plays a critical role in cellular defense against oxidative stress [39] . In conclusion, findings from this study demonstrated that Hepacare was significantly beneficial in the prevention of CCl 4 -induced hepatocellular injury, possibly by
